Browse By: Country ι Category ι Latest Reports ι Tag

Bone Cancer Global Clinical Trials Review, H1, 2014

Pages » 183
Published By » GlobalData
Price » $2500
In stock
View Report Details
Description

GlobalData's clinical trial report, Bone Cancer Global Clinical Trials Review, H1, 2014" provides data on the Bone Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bone Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bone Cancer. This report is built using data and information sourced from proprietary databases, prim... Click here for more details


Prostate Cancer - BRIC Drug Forecasts and Treatment Analysis to 2020
GlobalData\'s pharmaceutical report, Prostate Cancer Brazil, Russia, India and China (BRIC) Drug Forecasts and Treatment Analysis to 2020 is an essential source of information and analysis on the prostate cancer therapeutics market in the emerging BRIC countries. The report provides comprehensiv
Published Date: Dec 2010
Price: $3000
Prostate Cancer - US Drug Forecasts and Treatment Analysis to 2020
GlobalData\'s pharmaceutical report, Prostate Cancer US Drug Forecasts and Treatment Analysis to 2020 is an essential source of information and analysis on the US prostate cancer therapeutics market. The report provides comprehensive information on prostate cancer, highlighting the treatment gui
Published Date: Dec 2010
Price: $3000
Prostate Cancer - France Drug Forecasts and Treatment Analysis to 2020
GlobalData\'s pharmaceutical report, Prostate Cancer France Drug Forecasts and Treatment Analysis to 2020 is an essential source of information and analysis on the French prostate cancer therapeutics market. The report provides comprehensive information on prostate cancer, highlighting the treat
Published Date: Dec 2010
Price: $3000
Prostate Cancer - Spain Drug Forecasts and Treatment Analysis to 2020
GlobalData\'s pharmaceutical report, Prostate Cancer Spain Drug Forecasts and Treatment Analysis to 2020. The report is an essential source of information and analysis on the Spanish prostate cancer therapeutics market. The report provides comprehensive information on prostate cancer, highlighti
Published Date: Dec 2010
Price: $3000
Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020
GlobalData\'s pharmaceutical report, Prostate Cancer Italy Drug Forecasts and Treatment Analysis to 2020. The report is an essential source of information and analysis on the Italian prostate cancer therapeutics market. The report provides comprehensive information on prostate cancer, highlighti
Published Date: Dec 2010
Price: $3000
Prostate Cancer - Japan Drug Forecasts and Treatment Analysis to 2020
GlobalData\'s pharmaceutical report, Prostate Cancer Japan Drug Forecasts and Treatment Analysis to 2020 is an essential source of information and analysis on the Japanese prostate cancer therapeutics market. The report provides comprehensive information on prostate cancer, highlighting the trea
Published Date: Dec 2010
Price: $3000
Castration Resistant Prostate Cancer: Clinical Insights from a US Oncologists\' Survey
Progressively unfolding patient situation, presented to 154 oncologists in a survey for their open-ended responses providing rich insight into their clinical decisions. Data includes specific treatment and testing choices, factors that influence their decisions, barriers to optimal treatment a
Published Date: Mar 2011
Price: $2999
Prostate Cancer - Pipeline Assessment and Market Forecasts to 2020
GlobalData, the industry analysis specialist, has released its new report, “Prostate Cancer - Pipeline Assessment and Market Forecasts to 2020”. The report is an essential source of information and analysis on the global prostate cancer therapeutics market. The report provides detailed
Published Date: Dec 2010
Price: $3500
Sarcomas Global Clinical Trials Review, Q4, 2010
GlobalData's clinical trial report, Sarcomas Global Clinical Trials Review, Q4, 2010" provides data on the Sarcomas clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Sarcomas. It includes an overview of the trial numbers and their recrui
Published Date: Dec 2010
Price: $1000
Carcinomas Global Clinical Trials Review, Q4, 2010
GlobalData's clinical trial report, Carcinomas Global Clinical Trials Review, Q4, 2010" provides data on the Carcinomas clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Carcinomas. It includes an overview of the trial numbers and their
Published Date: Dec 2010
Price: $1000

 


 

Related News

Hygiene Hypothesis Corroborates Spike in Demand for Allergy Diagnostics
The global allergy diagnostic market has been booming over the past few years due to a proposed hygiene hypothesis. The theory claims that lack of exposure to allergens and dust or living in excessively hygienic conditions can make the human body prone to allergies as the immune system does not learn to fight. This theory has been proposed to back the increasing number of asthma cases amongst children, especially in the developed countries, where hygiene is given importance above its due. In add
Date: Oct 24

Globally Warming to Encourage Spread of Lethal Bacteria in Oceans Globally
It has already become evident that the increasing ocean temperatures have been making individuals sick and this is only becoming worse now. The bacteria that loves warmth is now growing in large numbers and is posing disastrous impacts on the human health, as per a study published recently. The bacteria called as Vibrio bacteria has caused around eighty thousand illnesses as well as about hundred deaths within the U.S alone in the past few years. Exceptional Count of Vibrio Cases in Northern Eu
Date: Aug 10

Global Paracetamol and PAP Market Fights an Uphill Battle
Paracetamol has been one of the most commonly used drugs in modern medicine. It has been used in the treatment of the most common ailments, including fever, cold, arthritis, and also major epidemics such as the swine flu. Consumers have shown a high rate of consumption of paracetamol as it provides almost instant relief from symptoms, is available everywhere as a generic drug, and is available as an over the counter drug in most countries. This includes the nations in North America, where the co
Date: Feb 18

Next-generation Antifungal Drugs Hold Promise for Dermatophytoses, Newer Therapeutics Overcome Shortcomings of Early Drugs
In the U.S., onychomycosis poses as a major public health problem, as it is prevalent in 10% of the population and its associated morbidity. Although not life-threatening, the fungal infection is a dermatophytic invasion of the nail plate. The infection can be present in any component of the nail unit, which includes the bed, matrix, or plate. Pain, discomfort, and disfigurement are the notable signs of onychomycosis, which may lead to significant physical and occupational limitations. The condi
Date: Jan 25

Despite Rise in Number of Erectile Dysfunction Cases, Revenue Generation from ED Drugs to Decline
This is probably one of the few times when availability of certain drugs is actually hampering the growth of a certain section of the health care market. The erectile dysfunction drugs market, over the past few decades, has been driven by the rising incidence of erectile dysfunction caused by environmental and genetic factors. However, there are several forces in the coming years that are anticipated to negatively impact the erectile dysfunction drugs market, causing it to register a -4.50 per c
Date: Jan 22

Chipotle and Costco E.coli Outbreaks Point out the Need for Advanced Testing Kit
During the period from October 2015 to November 2015, over 50 customers have been affected with E.coli after eating at Chipotle locations across Washington, Kansas, Oregon, and Oklahoma. More recently, 80 college students in Boston fell sick with the norovirus after contracting it from a single Chipotle location. By the end of 2015, more than 350 people became sick after eating at Chipotle. In early November, just after the Chipotle case had made headlines, another E.coli outbreak was reported i
Date: Jan 20

What the Newly Found Ebola Antibodies Mean for the Healthcare Industry
In what could be perceived to be one of the greater breakthroughs in the field of medicine, researchers have engineered the first antibodies that have the ability to neutralize two strains of the deadly Ebola-causing virus. The research was conducted on mice and is considered to be a major step in achieving immunization against all strains of Ebola. The research was led by Dr. Jonathan Lai. He stated that it is a tremendous advance to achieve a broadly effective Ebola immunotherapy. This is bec
Date: Jan 14

California Considering Exempting ‘Tampon Tax’
Growing awareness towards sanitation and urbanization has boosted the demand from the global feminine hygiene products market. In regions, especially Asia Pacific, several health programs focussed to raise awareness about sanitation across rural areas has augmented the market growth. Key market players such as Proctor & Gamble and Johnson & Johnson have partnered with governments in countries such as India to increase awareness among women regarding menstruation related health concerns. Rising c
Date: Jan 12

Aurobindo Pharma Latest to Join Line of Generic Drug Makers of Norethindrone Acetate
The United States Food and Drugs Association has officially given the nod of approval to Aurobindo Pharma to manufacture, sell, and market generic variants of norethindrone acetate within the U.S. market. The U.S. health regulator has provided Aurobindo Pharma with the vital agreement to create 5 mg strength tablets of norethindrone acetate, as said by an Aurobindo Pharma spokesperson in a recent statement. They later added that the drug has an estimated market size of US$42 mn for the twelve m
Date: Jan 11

Oral Contraceptive Pills Market Witnessing Surging Demand Particularly from Developed Regions
The market segment of oral contraceptive pills in the pharmaceutical industry is gearing to exhibit an exponential growth in the near future. The latest market studies published reveal promising growth prospects for the niche is very promising particularly due to the rising awareness about the pregnancy preventive methods, their corresponding benefits, and favorable reimbursement policies introduced by the policy makers.  Among the most prominent brands available in the market Loestrin and Bay
Date: Jan 07

Upcoming Reports

Oncology Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
Oncology is the study of Cancer. Oncology devices market consists of medical devices involved in diagnosing and treating the disease cancer. The Oncology devices market could be segmented into 2 major categories: by type and by applications. There are two types of Brachytherapy devices and the E
Published By: Transparency
Price: $5595
Biologicals In Oncology Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Biological therapy is defined as use of living organisms and substances derived from organism or synthetically produced version of such substances in laboratories to treat the disease condition. Some of the biological therapies for cancer involve vaccines or bacteria to stimulate the body’s de
Published By: Transparency
Price: $5795